Displaying 680 results out of a total of 3930 publications.
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer
Shee, K;Jiang, A;Varn, FS;Liu, S;Traphagen, NA;Owens, P;Ma, CX;Hoog, J;Cheng, C;Golub, TR;Straussman, R;Miller, TW;
FASEB J., FASEB J. ():fj201801241R, 2018
View publication
FASEB J., FASEB J. ():fj201801241R, 2018
A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis
Mishra, A;Pisco, A;Oules, B;Ly, T;Liakath-Ali, K;Walko, G;Viswanathan, P;Nijjhar, J;Dunn, S;Lamond, A;Watt, VO;
bioRxiv, bioRxiv ():, 2017
View publication
bioRxiv, bioRxiv ():, 2017
USP7 small-molecule inhibitors interfere with ubiquitin binding
Kategaya, L;Di Lello, P;Roug, L;Pastor, R;Clark, KR;Drummond, J;Kleinheinz, T;Lin, E;Upton, JP;Prakash, S;Heideker, J;McCleland, M;Ritorto, MS;Alessi, DR;Trost, M;Bainbridge, TW;Kwok, MCM;Ma, TP;Stiffler, Z;Brasher, B;Tang, Y;Jaishankar, P;Hearn, BR;Renslo, AR;Arkin, MR;Cohen, F;Yu, K;Peale, F;Gnad, F;Chang, MT;Klijn, C;Blackwood, E;Martin, SE;Forrest, WF;Ernst, JA;Ndubaku, C;Wang, X;Beresini, MH;Tsui, V;Schwerdtfeger, C;Blake, RA;Murray, J;Maurer, T;Wertz, IE;
Nature, Nature 550(7677):534-538, 2017
View publication
Nature, Nature 550(7677):534-538, 2017
MASTL overexpression promotes chromosome instability and metastasis in breast cancer
Rogers, S;McCloy, RA;Parker, BL;Gallego-Ortega, D;Law, AMK;Chin, VT;Conway, JRW;Fey, D;Millar, EKA;O'Toole, S;Deng, N;Swarbrick, A;Chastain, PD;Cesare, AJ;Timpson, P;Caldon, CE;Croucher, DR;James, DE;Watkins, DN;Burgess, A;
Oncogene, Oncogene ():, 2018
View publication
Oncogene, Oncogene ():, 2018
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation
Jin, X;Xu, XE;Jiang, YZ;Liu, YR;Sun, W;Guo, YJ;Ren, YX;Zuo, WJ;Hu, X;Huang, SL;Shen, HJ;Lan, F;He, YF;Hu, GH;Di, GH;He, XH;Li, DQ;Liu, S;Yu, KD;Shao, ZM;
Sci Adv, Sci Adv 5(3):eaat9820, 2019
View publication
Sci Adv, Sci Adv 5(3):eaat9820, 2019
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Berns, K;Caumanns, JJ;Hijmans, EM;Gennissen, AMC;Severson, TM;Evers, B;Wisman, GBA;Jan Meersma, G;Lieftink, C;Beijersbergen, RL;Itamochi, H;van der Zee, AGJ;de Jong, S;Bernards, R;
Oncogene, Oncogene ():, 2018
View publication
Oncogene, Oncogene ():, 2018
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
Chen, L;Yang, L;Yao, L;Kuang, XY;Zuo, WJ;Li, S;Qiao, F;Liu, YR;Cao, ZG;Zhou, SL;Zhou, XY;Yang, WT;Shi, JX;Huang, W;Hu, X;Shao, ZM;
Nat Commun, Nat Commun 9(1):1357, 2018
View publication
Nat Commun, Nat Commun 9(1):1357, 2018
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
Martin, LA;Ribas, R;Simigdala, N;Schuster, E;Pancholi, S;Tenev, T;Gellert, P;Buluwela, L;Harrod, A;Thornhill, A;Nikitorowicz-Buniak, J;Bhamra, A;Turgeon, MO;Poulogiannis, G;Gao, Q;Martins, V;Hills, M;Garcia-Murillas, I;Fribbens, C;Patani, N;Li, Z;Sikora, MJ;Turner, N;Zwart, W;Oesterreich, S;Carroll, J;Ali, S;Dowsett, M;
Nat Commun, Nat Commun 8(1):1865, 2017
View publication
Nat Commun, Nat Commun 8(1):1865, 2017
Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles
Matuszak, J;Lutz, B;Sekita, A;Zaloga, J;Alexiou, C;Lyer, S;Cicha, I;
Int J Nanomedicine, Int J Nanomedicine 13():8443-8460, 2018
View publication
Int J Nanomedicine, Int J Nanomedicine 13():8443-8460, 2018
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Pishas, KI;Lessnick, SL;
Oncotarget, Oncotarget 9(92):36413-36429, 2018
View publication
Oncotarget, Oncotarget 9(92):36413-36429, 2018